According to Immunome's latest financial reports the company's current EPS (TTM) is -$2.20. In 2022 the company made an earnings per share (EPS) of -$3.09 a decrease over its 2021 EPS that were of -$2.13.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.20 | -28.8% |
2022 | -$3.09 | 45.07% |
2021 | -$2.13 | 3.38% |
2020 | -$2.06 |